Siemens Healthineers gets CCI nod to acquire Varian Medical Systems

"Commission approves acquisition of 100% shares & sole control of Varian Medical Systems by Siemens Healthineers," the regulator said in a tweet.

Published On 2021-02-11 06:35 GMT   |   Update On 2021-02-11 06:35 GMT

New Delhi: The Competition Commission of India (CCI) on Wednesday said it has given nod to acquisition of 100 per cent shares and sole control of Varian Medical Systems by Siemens Healthineers.

As per a combination notice filed with the regulator, the transaction relates to the acquisition of 100 per cent shares of common stock and sole control of Varian by Siemens Healthineers Holding I GmbH, which is a wholly-owned subsidiary of Siemens Healthineers AG.

The proposed transaction will bring together Siemens Healthineers'' imaging equipment and Varian''s oncology treatment solutions, allowing for a more innovative, efficient and comprehensive oncology solutions provider, the notice said.

It will benefit cancer patients with improved treatments with the goal of ultimately turning cancer into a manageable disease, which is the driving rationale for the proposed transaction, it added.

Advertisement

"Commission approves acquisition of 100% shares & sole control of Varian Medical Systems by Siemens Healthineers," the regulator said in a tweet.

Read also: Eli Lilly, Asahi Kasei Pharma ink license agreement for chronic pain drug candidate

Besides, CCI approved subscription to securities of Ecom Express Pvt Ltd by CDC Group.

CDC is a development finance institution, wholly-owned by the UK government, while Ecom Express is engaged in providing third-party logistics services in India, as per a combination notice.


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News